Semi-Annual Statement Of Cash Flows

NANO MRNA Co.,Ltd. - Filing #7296479

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-517,215,000 JPY
-474,140,000 JPY
Depreciation
16,000 JPY
28,000 JPY
Impairment losses
784,000 JPY
4,040,000 JPY
Foreign exchange losses (gains)
25,199,000 JPY
-47,800,000 JPY
Decrease (increase) in trade receivables
20,350,000 JPY
-22,244,000 JPY
Decrease (increase) in inventories
-460,000 JPY
-1,576,000 JPY
Increase (decrease) in trade payables
210,000 JPY
-2,296,000 JPY
Other, net
36,851,000 JPY
37,735,000 JPY
Subtotal
-283,767,000 JPY
-339,279,000 JPY
Income taxes paid
-2,383,000 JPY
-2,490,000 JPY
Net cash provided by (used in) operating activities
-268,192,000 JPY
-330,332,000 JPY
Cash flows from investing activities
Purchase of securities
-2,400,000,000 JPY
-2,400,000,000 JPY
Other, net
-661,000 JPY
229,000 JPY
Net cash provided by (used in) investing activities
1,601,710,000 JPY
406,537,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
JPY
Net cash provided by (used in) financing activities
0 JPY
3,728,000 JPY
Effect of exchange rate change on cash and cash equivalents
-25,199,000 JPY
47,800,000 JPY
Net increase (decrease) in cash and cash equivalents
1,308,318,000 JPY
127,733,000 JPY
Cash and cash equivalents
2,883,581,000 JPY
1,575,263,000 JPY
1,437,326,000 JPY
1,309,592,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.